ARDELYX, INC.·4

Jan 9, 6:59 PM ET

Williams Laura A 4

4 · ARDELYX, INC. · Filed Jan 9, 2026

Insider Transaction Report

Form 4
Period: 2026-01-08
Williams Laura A
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-08$0.99/sh+50,000$49,500409,896 total
  • Sale

    Common Stock

    2026-01-08$6.98/sh50,000$348,900361,563 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2026-01-08062,000 total
    Exercise: $0.99Exp: 2032-01-06Common Stock (50,000 underlying)
Footnotes (3)
  • [F1]This transaction was executed in multiple trades in prices ranging from $6.97 to $7.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F2]Reflects the adjusted total which includes the purchase of 1,667 shares under the Ardelyx Employee Stock Purchase Plan in August 2025.
  • [F3]The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Documents

1 file
  • 4
    wk-form4_1768003182.xmlPrimary

    FORM 4